Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Vor Biopharma Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18
   10-K10-KS-1/A
Revenues  31.66.22.4
            Revenue growth  410.0%154.8% 
Cost of goods sold  63.212.42.9
Gross profit  -31.6-6.2-0.4
            Gross margin  -100.0%-100.0%-17.6%
Selling, general and administrative   [+]11.74.20.4
Other operating expenses    2.0
EBITDA   [+]-42.8-10.3-2.8
            EBITDA margin  -135.2%-166.5%-116.7%
Depreciation and amortization  0.60.10.0
EBIT   [+]-43.4-10.4-2.9
            EBIT margin  -137.2%-168.0%-117.6%
Other income (expense), net  -5.9-2.2-1.3
Pre-tax income  -49.3-12.6-4.2
Income taxes  0.00.00.0
            Tax rate  0.0%0.0%0.0%
Net income  -49.3-12.6-4.2
            Net margin  -155.8%-203.4%-170.7%
   
Basic EPS   [+]($230.56)($109.71)($47.30)
Diluted EPS   [+]($230.56)($109.71)($47.30)
   
Shares outstanding (basic)   [+]0.20.10.1
Shares outstanding (diluted)   [+]0.20.10.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy